Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- 1242-035 No ClinicalTrials.gov identifier reported
- 1245.0092 Non-interventional study of the safety and effectiveness of empagliflozin in patients with type 2 diabetes compared with DPP-4 inhibitors in the United States. No ClinicalTrials.gov identifier reported
- 125134 Study 550 No ClinicalTrials.gov identifier reported
- 125134 Study 551 No ClinicalTrials.gov identifier reported
- 12 and 18Month Outcomes and Longterm Survival of Tofacitinib in Ulcerative Colitis No ClinicalTrials.gov identifier reported
- 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe NCT05600426
- 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe No ClinicalTrials.gov identifier reported
- 12-month effectiveness and tolerability of brivaracetam in the real-world: interim analysis of the international, non-interventional EXPERIENCE study No ClinicalTrials.gov identifier reported
- 12-month effectiveness and tolerability of brivaracetam in the real world the international, non-interventional EXPERIENCE study No ClinicalTrials.gov identifier reported
- 12-month effectiveness and tolerability of brivaracetam in the real world: the international, non-interventional EXPERIENCE study No ClinicalTrials.gov identifier reported
- 12-Month effectiveness and tolerability of brivaracetam in the real world the international, noninterventional EXPERIENCE study No ClinicalTrials.gov identifier reported
- 12-Month effectiveness and tolerability of brivaracetam in the real world: the international, noninterventional EXPERIENCE study No ClinicalTrials.gov identifier reported
- 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema: The FARETINA-DME Study No ClinicalTrials.gov identifier reported
- 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Neovascular Age-Related Macular Degeneration: FARETINA-AMD No ClinicalTrials.gov identifier reported
- 12-Month Real-World Clinical Outcomes in Patients With Diabetic Macular Edema Treated With Faricimab in the USA: The FARETINA-DME Study No ClinicalTrials.gov identifier reported
- 12 months follow-up observational extension of ILQ137-C002 study (Clareon PanOptix vs Clareon PanOptix IOLs) No ClinicalTrials.gov identifier reported
- 12-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis No ClinicalTrials.gov identifier reported
- 13-003 A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence No ClinicalTrials.gov identifier reported
- (13-003) A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence No ClinicalTrials.gov identifier reported
- (13-003) Ind2 No ClinicalTrials.gov identifier reported
- 131462 No ClinicalTrials.gov identifier reported
- 133421 No ClinicalTrials.gov identifier reported
- 1346-P02: BI 425809 - Schizophrenia - Project Committee(s) No ClinicalTrials.gov identifier reported
- 13-583 No ClinicalTrials.gov identifier reported
- 13-583_R No ClinicalTrials.gov identifier reported
- 13-601 No ClinicalTrials.gov identifier reported
- 13-601 NCT01994382
- 1385 PI: Smoyer, Dr. William E. - Voclosporin effect on molecular pathways and lipids in nephrotic syndrome No ClinicalTrials.gov identifier reported
- 13US-T404 An open-label therapeutic efficacy study of Tirosint (levothyroxine sodium) capsules in thyroidectomized patients taking proton pump inhibitor No ClinicalTrials.gov identifier reported
- 13US-T404 /An open-label therapeutic efficacy study of Tirosint (levothyroxine sodium) capsules in thyroidectomized patients taking proton pump inhibitor- No ClinicalTrials.gov identifier reported
- 13Y-US-1029 No ClinicalTrials.gov identifier reported
- 13Y-US-1029 No ClinicalTrials.gov identifier reported
- 13Y-US-1029 No ClinicalTrials.gov identifier reported
- 1401: Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell /Myeloma Fusions No ClinicalTrials.gov identifier reported
- 1401: Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell /Myeloma Fusions (RV-CL-MM-BMTCTN-005339) No ClinicalTrials.gov identifier reported
- 1404-P02: BI 456906 Duale Agonists (Obesity) - Project Committee(s) No ClinicalTrials.gov identifier reported
- 14-059 No ClinicalTrials.gov identifier reported
- 14059 NCT03379428
- 14-09 Zenith p-Branch Endovascular Graft - Pivotal Study No ClinicalTrials.gov identifier reported
- (14-09) Zenith p-Branch Endovascular Graft - Pivotal Study No ClinicalTrials.gov identifier reported
- 141106 NCT02315768
- 14.15872 Asar No ClinicalTrials.gov identifier reported
- 14.1588 K-0180 No ClinicalTrials.gov identifier reported
- 14.1588 K-180 No ClinicalTrials.gov identifier reported
- 14-193 No ClinicalTrials.gov identifier reported
- 14-296 No ClinicalTrials.gov identifier reported
- 14-296 No ClinicalTrials.gov identifier reported
- 145-12 (DUO Ext) NCT02049515
- 145-23 (Rollover) NCT02711852
- (14C)-CV010 - A Phase I, Open-Label Study of the Absorption, Metabolism and Excretion Following a Single Oral Dose to Healthy Male Subjects NCT03210909